Search | TVST | ARVO Journals

Showing 1 – 20 of 45

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Reduction of pathological retinal neovascularization, vessel obliteration and artery tortuosity by PEDF protein-based therapeutic in an oxygen-induced ischemic retinopathy rat model

SHIYING ZHAO; Alexander Tschulakow; Subha Karthikeyan; Kun Wang; Stefan Kochanek; Ulrich Schraermeyer; Sylvie Julien-Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):284.

ARVO Annual Meeting Abstract June 2023

Pigment epithelium-derived factor (PEDF) based therapy induced photoreceptor survival by stabilising the neovessels in a VEGF overexpression CNV rat model

Alexander Viktor Tschulakow; Lei Xi; Ulrich Schraermeyer; Sylvie Julien-Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1133.

ARVO Annual Meeting Abstract July 2019

Stabilization and supporting blood vessel growth as a new concept to treat wet AMD

Sylvie Julien; Alexander Tschulakow; Harsh Thakkar; Shan Liu; Barbara Illing; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):366.

ARVO Annual Meeting Abstract July 2019

Degradation of lipofuscin in Stargardt mice can be enhanced by the superoxide generator riboflavin - a hypothesis for melanolipofuscin formation

Ulrich Schraermeyer; Yuan Fang; Tatjana Taubitz; Alexander Tschulakow

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1912.

ARVO Annual Meeting Abstract July 2019

The three dimensional (3D) ultrastructure of VEGF driven choroidal neovascularisation in the rat

Antje Biesemeier; Shan Liu; Alexander Tschulakow; Barbara Illing; Harsh Thakkar; Yuan Fang; Birgit Schroeppel; Claus Burkhardt; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2980.

ARVO Annual Meeting Abstract July 2019

Short-wavelength and near-Infrared fundus autofluorescence in blue light-illuminated Abca4 -/- mice and a patient with Stargardt disease

Yuan Fang; Alexander Tschulakow; Tatjana Taubitz; Barbara Illing; Antonina Burda; Antje Biesemeier; Sylvie Julien; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5982.

Review September 2017

Towards Treatment of Stargardt Disease: Workshop Organized and Sponsored by the Foundation Fighting Blindness

PDF

Avery E. Sears; Paul S. Bernstein; Artur V. Cideciyan; Carel Hoyng; Peter Charbel Issa; Krzysztof Palczewski; Philip J. Rosenfeld; SriniVas Sadda; Ulrich Schraermeyer; Janet R. Sparrow; Ilyas Washington; Hendrik P.N. Scholl
TAGS: blindness, stargardt's disease
Trans. Vis. Sci. Tech.. 2017; 6(5):6. https://doi.org/10.1167/tvst.6.5.6

ARVO Annual Meeting Abstract June 2017

Effect of the pre-treatment with the radioprotector ortho-phospho-L-tyrosine (pTyr) in a xenograft retinoblastoma mouse model

Alexander Viktor Tschulakow; H. Peter Rodemann; Stephan M. Huber; Monika Rittgarn; Dominik Klumpp; Benjamin Steegen; Ulrich Schraermeyer; Sylvie Julien-Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1775.

ARVO Annual Meeting Abstract June 2017

Hypoxia and VEGF overexpression induce the formation of labyrinth capillaries, which are described to be responsible for leakage in wet AMD

Antje Kristina Biesemeier; Shan Liu; Marina Tikhonovich; Guido Hartmann; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2264.

ARVO Annual Meeting Abstract June 2017

A valid ultrastructural rat choroidal neovascularization model developed by overexpression of VEGF

Shan Liu; Alexander Viktor Tschulakow; Sylvie Julien-Schraermeyer; Ulrich Schraermeyer; Antje Kristina Biesemeier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2269.

ARVO Annual Meeting Abstract June 2017

Hypoxia induces formation of capillaries that resemble leaky vessels in CNV

Marina Valerevna Tikhonovich; Antje Biesemeier; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4078.

ARVO Annual Meeting Abstract June 2017

Preclinical results of a new pharmacological therapy approach for Stargardt disease and dry age-related macular degeneration

Yuan Fang; Alexander Tschulakow; Marina Tikhonovich; Tatjana Taubitz; Barbara Illing; Sigrid Schultheiss; Ulrich Schraermeyer; Sylvie Julien-Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):256.

ARVO Annual Meeting Abstract June 2017

Testing a new pharmacological therapy approach for the removal of lipofuscin in vitro : results from a newly established culture of aged primary Stargardt mouse model RPE cells and aged primary human RPE cells

Tatjana Taubitz; Yuan Fang; Monika Rittgarn; Ulrich Schraermeyer; Sylvie Julien-Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):257.

ARVO Annual Meeting Abstract June 2017

Unravelling the mystery of the Stiles Crawford Effect

Ulrich Schraermeyer; Sigrid Schultheiss; Theo Oltrup; Thomas Bende; Sebastian Schmelzle; Alexander Tschulakow

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5603.

ARVO Annual Meeting Abstract September 2016

Transition metals and trace elements in the retinal pigment epithelium and neighbouring structures: correlative ultrastructural and chemical analysis by analytical electron microscopy and nano-secondary ion mass spectrometry.

Antje Kristina Biesemeier; Oliver Eibl; Santhana Moorthy; Jean- Nicolas Audinot; Tom Wirtz; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract June 2015

Effects of pretreatment with the radioprotector ortho-phospho-L-tyrosine (pTyr) on Rb+/- mice after radiation exposure - Implication for the treatment of retinoblastoma patients with radiotherapy

Alexander Tschulakow; Stephan Huber; Monika Rittgarn; Hans-Peter Rodemann; Ulrich Schraermeyer; Sylvie Julien; Section of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Tuebingen, Germany

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):72.

ARVO Annual Meeting Abstract June 2015

Intravitreal injection of Fc-fragments has multiple adverse effects on retina and choroid

Ulrich Schraermeyer; Tatjana Taubitz; Laura-Pia Steinbrenner; Tobias Peters; Antje Kristina Biesemeier; Monika Rittgarn; Sigrid Schultheiss; Alexander Tschulakow; Sylvie Julien

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1511.

ARVO Annual Meeting Abstract June 2015

Pericytes are more abundant in vessels of eyes affected by wet age-related macular degeneration as compared to those of age-matched controls

Antje Kristina Biesemeier; Nan Su; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3538.

ARVO Annual Meeting Abstract June 2015

Removal of lipofuscin from the RPE of Abca4 -/- mice with THPE: quantitative and toxicity studies

Tatjana Taubitz; Tobias Peters; Simone Pöschel; Alexander Tschulakow; Monika Rittgarn; Sigrid Schultheiss; Katja Schenke-Layland; Michael Burnet; Sylvie Julien; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4199.

ARVO Annual Meeting Abstract April 2014

Choroidal neovascularization can help photoreceptors to survive in late AMD.

Antje Kristina Biesemeier; Sylvie Julien; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1186.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Reduction of pathological retinal neovascularization, vessel obliteration and artery tortuosity by PEDF protein-based therapeutic in an oxygen-induced ischemic retinopathy rat model

Pigment epithelium-derived factor (PEDF) based therapy induced photoreceptor survival by stabilising the neovessels in a VEGF overexpression CNV rat model

Stabilization and supporting blood vessel growth as a new concept to treat wet AMD

Degradation of lipofuscin in Stargardt mice can be enhanced by the superoxide generator riboflavin - a hypothesis for melanolipofuscin formation

The three dimensional (3D) ultrastructure of VEGF driven choroidal neovascularisation in the rat

Short-wavelength and near-Infrared fundus autofluorescence in blue light-illuminated Abca4 -/- mice and a patient with Stargardt disease

Towards Treatment of Stargardt Disease: Workshop Organized and Sponsored by the Foundation Fighting Blindness

Effect of the pre-treatment with the radioprotector ortho-phospho-L-tyrosine (pTyr) in a xenograft retinoblastoma mouse model

Hypoxia and VEGF overexpression induce the formation of labyrinth capillaries, which are described to be responsible for leakage in wet AMD

A valid ultrastructural rat choroidal neovascularization model developed by overexpression of VEGF

Hypoxia induces formation of capillaries that resemble leaky vessels in CNV

Preclinical results of a new pharmacological therapy approach for Stargardt disease and dry age-related macular degeneration

Testing a new pharmacological therapy approach for the removal of lipofuscin in vitro : results from a newly established culture of aged primary Stargardt mouse model RPE cells and aged primary human RPE cells

Unravelling the mystery of the Stiles Crawford Effect

Transition metals and trace elements in the retinal pigment epithelium and neighbouring structures: correlative ultrastructural and chemical analysis by analytical electron microscopy and nano-secondary ion mass spectrometry.

Effects of pretreatment with the radioprotector ortho-phospho-L-tyrosine (pTyr) on Rb+/- mice after radiation exposure - Implication for the treatment of retinoblastoma patients with radiotherapy

Intravitreal injection of Fc-fragments has multiple adverse effects on retina and choroid

Pericytes are more abundant in vessels of eyes affected by wet age-related macular degeneration as compared to those of age-matched controls

Removal of lipofuscin from the RPE of Abca4 -/- mice with THPE: quantitative and toxicity studies

Choroidal neovascularization can help photoreceptors to survive in late AMD.

To View More...

You must be signed into an individual account to use this feature.